Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Teplizumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sanofi to acquire Provention Bio for $2.9 billion
    Sanofi to acquire Provention Bio for $2.9 billion

    14 Mar 2023

    // PRESS RELEASE

    https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13-06-00-00-2625367

    PRESS RELEASE
    14 Mar 2023
    Share Share
    Provention Bio Announces Closing of Second Tranche with Hercules Capital
    Provention Bio Announces Closing of Second Tranche with Hercules Capital

    02 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/provention-bio-announces-closing-of-second-tranche-with-hercules-capital-to-support-us-commercial-launch-of-tzield-301737909.html

    PR NEWSWIRE
    02 Feb 2023
    Share Share
    2022 drug approvals: Biopharma delivered 37 new drugs
    2022 drug approvals: Biopharma delivered 37 new drugs

    03 Jan 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/special-reports/2022-drug-approvals-after-aduhelm-fiasco-fda-endorsements-were-harder-come

    Kevin Dunleavy FIERCE PHARMA
    03 Jan 2023
    Share Share
    Almac Pharma Services Supports Launch of Provention Bio’s TZIELD
    Almac Pharma Services Supports Launch of Provention Bio’s TZIELD

    13 Dec 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-12-13/almac-pharma-services-supports-launch-of-provention-bios-tzield/?widget=listSection

    CONTRACTPHARMA
    13 Dec 2022
    Share Share
    JDRF and its affiliates celebrate Teplizumab approval
    JDRF and its affiliates celebrate Teplizumab approval

    22 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/11/22/2561000/0/en/JDRF-and-its-affiliates-celebrate-Teplizumab-approval.html

    GLOBENEWSWIRE
    22 Nov 2022
    Share Share
    Amber Specialty Pharmacy Selected to Dispense TZIELD
    Amber Specialty Pharmacy Selected to Dispense TZIELD

    21 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221121005921/en

    BUSINESSWIRE
    21 Nov 2022
    Share Share